2021 CMSC Annual Meeting

Go back to the CMSC Education Website
Search

Tag: (3)Rocky Mountain Multiple Sclerosis Clinic and Research Group

Poster-Disease-modifying Therapy

October 25, 2021

Analysis of Health Care Provider Reasons for Switching to Diroximel Fumarate from Other Disease-Modifying Therapies

Background: Switching of disease-modifying therapies (DMTs) for treatment of multiple sclerosis (MS) is driven by many factors that are not...

Read More →
MAILING ADDRESS

3 University Plaza Drive, Ste 116
Hackensack, NJ 07601

CONTACT US

(201) 487-1050
info@mscare.org

FOLLOW US
Facebook-f Twitter Linkedin Youtube

© 2021 CMSC